Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prerna Arora

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Arthroplasty|May 28, 2025
High Prophage Count in Staphylococcus Periprosthetic Joint Infection Is Associated With an Increase in Antibiotic Resistance GenesTony H Chang, Robert Manasherob, Sankalp Mrutyunjaya, et al.
The Journal of Trauma and Acute Care Surgery|June 15, 2012
The association between positive screen for future persistent posttraumatic stress symptoms and injury incident variables in the pediatric trauma care settingSarah V Duzinski, Karla A Lawson, R Todd Maxson, et al.
The Journal of Arthroplasty|October 10, 2025
Circulating Bacteriophage DNA Distinguishes Staphylococcal Infection From Commensal ColonizationRobert Manasherob, Daisuke Furukawa, Naomi L Haddock, et al.
Frontiers in Immunology|October 3, 2022
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsAnja Schlör, Stefan Hirschberg, Ghada Ben Amor, et al.
The Lancet. Infectious Diseases|November 3, 2022
The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineagesPrerna Arora, Lu Zhang, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|March 3, 2023
Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5Markus Hoffmann, Prerna Arora, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|May 8, 2023
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineageInga Nehlmeier, Amy Kempf, Prerna Arora, et al.
Journal of Virology|January 10, 2025
Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484DPrerna Arora, Lu Zhang, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|October 12, 2021
Delta variant (B.1.617.2) sublineages do not show increased neutralization resistancePrerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|May 17, 2022
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2Prerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Arthroplasty|May 28, 2025
High Prophage Count in Staphylococcus Periprosthetic Joint Infection Is Associated With an Increase in Antibiotic Resistance GenesTony H Chang, Robert Manasherob, Sankalp Mrutyunjaya, et al.
The Journal of Trauma and Acute Care Surgery|June 15, 2012
The association between positive screen for future persistent posttraumatic stress symptoms and injury incident variables in the pediatric trauma care settingSarah V Duzinski, Karla A Lawson, R Todd Maxson, et al.
The Journal of Arthroplasty|October 10, 2025
Circulating Bacteriophage DNA Distinguishes Staphylococcal Infection From Commensal ColonizationRobert Manasherob, Daisuke Furukawa, Naomi L Haddock, et al.
Frontiers in Immunology|October 3, 2022
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsAnja Schlör, Stefan Hirschberg, Ghada Ben Amor, et al.
The Lancet. Infectious Diseases|November 3, 2022
The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineagesPrerna Arora, Lu Zhang, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|March 3, 2023
Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5Markus Hoffmann, Prerna Arora, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|May 8, 2023
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineageInga Nehlmeier, Amy Kempf, Prerna Arora, et al.
Journal of Virology|January 10, 2025
Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484DPrerna Arora, Lu Zhang, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|October 12, 2021
Delta variant (B.1.617.2) sublineages do not show increased neutralization resistancePrerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|May 17, 2022
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2Prerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Pageof 10